JP Morgan Put 290 AMGN 20.06.2025/ DE000JK6CQS7 /
15/01/2025 12:59:00 | Diferencia+0.19 | Bid13:42:13 | Ask13:42:13 | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
3.13EUR | +6.46% | 3.07 Volumen de oferta: 7,500 |
3.13 Tamaño/ Volumen/ Formato de Ask: 7,500 |
Amgen Inc | 290.00 USD | 20/06/2025 | Put |
GlobeNewswire
29/08/2024
Great Place To Work Announces the 2024 Best Workplaces in Asia Representing 6.9 Million Employee Exp...
GlobeNewswire
28/08/2024
Prevent Cancer Annual Gala to celebrate three decades of commitment to cancer prevention and early d...
GlobeNewswire
15/08/2024
Alvotech Reports Record Revenues and Adjusted EBITDA for the Second Quarter and First Six Months of ...
GlobeNewswire
12/08/2024
TScan Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
08/08/2024
CytomX Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
08/08/2024
Ardelyx Appoints Experienced Biopharma Executive, Eric Foster, as Chief Commercial Officer
GlobeNewswire
05/08/2024
Avalyn Appoints Erin Lavelle, Seasoned Biopharma Finance Executive, to its Board of Directors
GlobeNewswire
01/08/2024
CytomX Therapeutics to Report Second Quarter 2024 Financial Results on August 8, 2024
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página